Published online before print July 10, 2003, doi: 10.1161/01.STR.0000081985.44625.B6
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:1892.)
© 2003 American Heart Association, Inc.
Original Contributions |
Prediction of Malignant Middle Cerebral Artery Infarction by Early Perfusion- and Diffusion-Weighted Magnetic Resonance Imaging
From the Klinik und Poliklinik für Neurologie (G.J.T., R.K., C.W., J.R.); Neuroradiologische Abteilung, Klinik und Poliklinik für Radiologie (T.K., J.F., H.Z.); and Institut für Mathematik und Datenverarbeitung in der Medizin (V.S.), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Correspondence to Götz Thomalla, MD, Klinik und Poliklinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, D-20246 Hamburg, Germany. E-mail thomalla{at}uke.uni-hamburg.de
 |
Abstract |
|---|
 Top Abstract IntroductionSubjects and MethodsResultsDiscussionConclusionsReferences |
|---|
Background and Purpose— We tested the hypothesis that early diffusion- and perfusion-weighted MRI (DWI and PWI, respectively) allows the prediction of malignant middle cerebral artery (MCA) infarction (MMI).
Methods— Thirty-seven patients with acute MCA infarction and proximal vessel occlusion (carotid-T, MCA main stem) were studied by DWI, PWI, and MR angiography within 6 hours of symptom onset. Eleven patients developed MMI, defined by decline of consciousness and radiological signs of space-occupying brain edema. Lesion volumes were retrospectively defined as apparent diffusion coefficient <80% (ADC<80%) and time to peak >+4 seconds (TTP>+4s) compared with the unaffected hemisphere. ADC decrease within the infarct core (ADCcore) and relative ADC within the ADC<80% lesion (rADClesion) were measured. Neurological deficit at admission was assessed with the National Institutes of Health Stroke Scale (NIHSS).
Results— Patients with MMI showed larger ADC<80% (median, 157 versus 22 mL; P<0.001) and TTP>+4s (208 versus 125 mL; P<0.001) lesion volumes, smaller TTP/ADC mismatch ratio (1.5 versus 5.5; P<0.001), lower ADCcore values (290 versus 411 mm2/s; P<0.001), lower rADClesion (0.60 versus 0.66; P=0.001), higher frequency of carotid-T occlusion (64% versus 15%; P=0.006), and higher NIHSS score at admission (20 versus 15; P=0.001). Predictors of MMI were as follows for sensitivity and specificity, respectively: ADC<80% >82 mL, 87%, 91%; TTP>+4s >162 mL, 83%, 75%; TTP/ADC mismatch ratio <2.4, 80%, 79%; ADCcore <300 mm2/s, 83%, 85%; rADClesion <0.62, 79%, 74%; and NIHSS score at admission 
19, 96%, 72%.
Conclusions— Quantitative analysis of early DWI and PWI parameters allows the prediction of MMI and can help in the selection of patients for aggressive tissue-protective therapy.
Key Words: brain edema • magnetic resonance imaging, diffusion-weighted • magnetic resonance imaging, perfusion-weighted • stroke, acute
|
Introduction |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionConclusionsReferences |
|---|
Large infarctions in the middle cerebral artery (MCA) territory may develop space-occupying brain edema, leading to midline shift, raised intracranial pressure, and herniation.1,2 The clinical course in these patients is characterized by deterioration of consciousness and signs of brain stem herniation usually occurring within 2 to 5 days.2,3 This subgroup of MCA strokes has been labeled malignant MCA infarction (MMI).4
Whereas mortality in overall acute MCA stroke ranges between 5% and 25%,5–7 mortality of large MCA infarction varies between 40% and 100%.3–5,7–10 Conservative treatment results in mortality rates of approximately 80%.3,8 Therefore, aggressive therapeutic approaches are recommended for this group of patients.
Decompressive craniectomy has been shown to reduce mortality and to improve outcome in patients with MMI in several case series10,11 (see Steiner et al12 for review). There is some evidence that early craniectomy is more effective than decompression at later time points. In a prospective case series, a stepwise reduction of time between stroke onset and surgery from 39 to 21 hours resulted in a further reduction of mortality from 27% to 16%.11 Therefore, the early identification of patients likely to develop MMI appears crucial.
See Editorial Comment, page 1899
A number of possible predictors of MMI have been identified, as follows: (1) clinical and/or laboratory findings such as coma on admission13; nausea, vomiting, or systolic blood pressure >180 mm Hg within the first 24 hours14; and history of hypertension, history of heart failure, or elevated white blood cell count9; (2) cranial CT (CCT) findings such as major early signs of ischemia covering >30%15 or >50% MCA territory,9,14,16,17 CCT lesion volume >240 mL18 or >400 mL,13 hyperdense MCA sign,16 local brain swelling,17 or midline shift13; (3) angiographic findings such as carotid-T occlusion15; (4) perfusion parameters such as cerebral blood flow measured by xenon CT19 or 99mtechnetium-ethyl-cysteinate-dimer single-photon emission CT20; and (5) MRI findings such as diffusion lesion volume >145 mL within 14 hours of symptom onset and apparent diffusion coefficient (ADC) decrease in different regions of interest (ROIs).21
Multiparametric MRI has been proposed as a new diagnostic standard of acute stroke management.22,23 Acute stroke MRI combining diffusion- and perfusion-weighted MRI (DWI and PWI, respectively), MR angiography (MRA), and heme-sensitive MR images (T2*-weighted images) supplies information on ischemic tissue (DWI), perfusion deficit (PWI), and vessel occlusion (MRA) and detects intracerebral hemorrhage (T2*-weighted images) within 1 session with examination times of <20 minutes.24–28 We tested the hypothesis that acute stroke MRI provides parameters that allow the prediction of MMI within the first 6 hours of stroke onset.
|
Subjects and Methods |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionConclusionsReferences |
|---|
Patients
We retrospectively analyzed data of patients admitted to our hospital from January 2000 to November 2001 for the diagnosis of acute stroke. Inclusion criteria were as follows: (1) acute MCA stroke with well-defined onset; (2) stroke MRI (PWI, DWI, MRA) performed within 6 hours of symptom onset; and (3) proximal vessel occlusion (carotid-T or MCA main stem occlusion) shown by MRA. Patients enrolled in randomized trials of neuroprotective agents or thrombolytic drugs were excluded from the analysis.
Diagnosis of MMI was based on clinical course and follow-up imaging (CCT or MRI) according to the following criteria: (1) secondary neurological deterioration including at least decline of consciousness as defined by 1 or more points on the level of consciousness item of the National Institutes of Health Stroke Scale (NIHSS) and (2) large space-occupying MCA infarction on follow-up MRI or CCT (covering more than two thirds of the MCA territory with compression of ventricles or midline shift) assessed in consensus by an experienced neurologist (J.R.) and neuroradiologist (T.K.).
All patients were admitted to the stroke unit or neurological intensive care unit. Patients were treated by intravenous or intra-arterial thrombolysis according to Second European-Australasian Acute Stroke Study Investigators (ECASS II)29 or Prolyse in Acute Cerebral Thromboembolism (PROACT II)30 criteria. Decompressive hemicraniectomy was performed in consensus by an experienced neurologist and neurosurgeon according to an institutional protocol.
Clinical Assessment
Severity of neurological deficit at admission was assessed by a neurologist using the NIHSS.31 Outcome was assessed with the Barthel Index32 and the modified Rankin Scale33 at day 90. Etiology of stroke was classified according to Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.34
MRI Protocol
MRI studies were performed with a 1.5-T scanner equipped with a 20-mT/m gradient system (Magnetom Symphony, Siemens). DWI, PWI, T2*-weighted imaging, fluid-attenuated inversion recovery (FLAIR) sequence, and a time-of-flight MRA were acquired within a standardized protocol within approximate 20 minutes. Details of the MRI protocol and the postprocessing procedure were reported recently.35 Diagnosis of vessel occlusion was based on MRA and dichotomized into carotid-T and MCA main stem occlusion. Occlusion of the extracranial internal carotid artery with accompanying MCA main stem occlusion was classified as MCA main stem occlusion. Examples of MRI studies are shown in the Figure.
|
Volume Measurement and ROI Analysis
Diffusion and perfusion lesion volumes were measured on ADC and time to peak (TTP) maps with a semiautomatic threshold procedure. First, the average ADC value of the unaffected hemisphere was determined with an upper threshold of ADC <1000 mm2/s to eliminate partial volume effects resulting from high ADC values from cerebrospinal fluid. Second, the lesion area was traced manually with a generous safety margin. Third, a threshold function was applied within this area with the use of an 80% threshold of the contralateral mean ADC. A similar procedure was performed on the TTP maps, first defining the mean TTP of the unaffected hemisphere, then tracing the visible lesion, and finally applying a threshold of a TTP delay of >4 seconds compared with the contralateral mean TTP for each slice. Pixel numbers resulting from this procedure were multiplied with voxel size to obtain ADC <80% (ADC<80%) and TTP >+4 seconds (TTP>+4s) lesion volumes. TTP/ADC mismatch ratio (ADC<80%/TTP>+4s) was calculated. The readers of the MRI scans (G.J.T. and T.K.) were blinded to the clinical status of the patients.
ADC changes were assessed in different ROIs as previously suggested.21 ADC decrease within the infarct core (ADCcore) was measured in a 9x9-voxel ROI centered in the area with the smallest ADC values within the infarct core. Relative ADC within the ADC<80% lesion (rADClesion) was calculated as the mean ADC value within the ADC<80% lesion compared with the mean ADC in the unaffected hemisphere.
Statistical Analysis
Patients were divided into MMI and non-MMI patients. Data are presented as median (range) for continuous variables and counts (percentage) for categorical variables. The 2 groups were compared for demographic, clinical, and MRI parameters with the Mann-Whitney U test for continuous parameters and Fisher exact test for categorical variables (SPSS 9.0.1, SPSS Inc). All probability values are interpreted descriptively in the context of an exploratory data analysis. For parameters that showed group differences with P<0.01, conventional binormal receiver operating characteristic (ROC) analysis was performed with the use of statistical software (ROCKIT 0.9B; www-radiology.uchicago.edu/klar/toppage11.html). From these curves, sensitivity, specificity, positive predictive values, and negative predictive values for the prediction of MMI were calculated. Thresholds result from the smoothed ROC curves and were chosen to maximize sensitivity and specificity equally. Additionally, 95% CIs are based on normal assumption,36 and 95% confidence limits for positive predictive values and negative predictive values are computed as exact binomial intervals.
|
Results |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionConclusionsReferences |
|---|
Within the study period, 105 patients with acute MCA stroke and well-defined symptom onset were studied by MRI within the first 6 hours. Forty-two patients met the inclusion criteria. Five of these patients were excluded for the following reasons: early death due to cardiac failure (n=1) and enrollment in randomized clinical trials (n=4; 1 of these patients developed MMI). Sixty-three patients did not meet the inclusion criteria: in 43 patients MRA showed only MCA branch or no vessel occlusion and in 19 patients the MRI protocol was incomplete (2 of these developed MMI). One patient had symptomatic hemorrhage after intravenous thrombolysis; this patient was not categorized as having MMI. Thirty-seven patients were finally included; 11 developed MMI, and 26 did not.
Demographic and clinical features are summarized in Tables 1 and 2 
. MMI and non-MMI patients were similar regarding age,sex, side of infarction, etiology, and time from symptom onset to MRI. The number of infarctions covering the complete MCA territory was higher in the MMI group (73% versus 4%). Patients with MMI presented with higher NIHSS score at admission (20 versus 15; P=0.001) and a higher frequency of carotid-T occlusion (64% versus 15%; P=0.006). A greater number of patients were treated by thrombolysis in the non-MMI group. Clinical outcome at 3 months was worse in the MMI group, with all surviving patients being dependent compared with a large number of independent patients in the non-MMI group (modified Rankin Scale score, 4 versus 1 [P<0.001]; Barthel Index score, 13 versus 100 [P=0.001]).
|
|
Within the MMI group, 7 patients were treated with hemicraniectomy 6 to 36 hours from symptom onset (
12 hours in 5 patients, 13 to 36 hours in 2 patients). Four patients were treated conservatively. All patients treated with hemicraniectomy survived, with modified Rankin Scale score of 3 to 4 (median, 4) at day 90. Three of the 4 conservatively treated patients died 2 to 7 days after onset; the surviving patient presented at day 90 with a modified Rankin Scale score of 4 (see Tables 1 and 2
for clinical data of MMI patients).
Patients with MMI showed larger ADC<80% lesion volumes (157 versus 22 mL; P<0.001), more extensive TTP>+4s lesion volumes (208 versus 125 mL; P<0.001), and a smaller TTP>+4s/ADC<80% mismatch ratio (1.5 versus 5.5; P<0.001) (Table 3). ADCcore (290 versus 411 mm2/s; P<0.001) and rADClesion (0.60 versus 0.66; P=0.001) were lower in MMI patients.
|
The following MRI parameters predicted MMI with high sensitivity and specificity (Table 4): ADC<80% >82 mL (87% sensitivity; 91% specificity), TTP>+4s >162 mL (83% sensitivity; 75% specificity), TTP/ADC mismatch ratio <2.4 (80% sensitivity; 79% specificity), ADCcore <300 mm2/s (83% sensitivity; 85% specificity), and rADClesion <0.62 (79% sensitivity; 74% specificity). NIHSS score at admission 19 appeared to predict MMI with high sensitivity (96%) but rather low specificity (72%). Carotid-T occlusion seemed to be only a moderate predictor with only 64% sensitivity but 85% specificity.
|
|
Discussion |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionConclusionsReferences |
|---|
We tested the value of a routine stroke MRI protocol for the prediction of MMI in acute stroke patients within 6 hours of symptom onset. We identified several parameters that predicted MMI with high sensitivity and specificity within the 6-hour time window: diffusion lesion volume, perfusion lesion volume, perfusion/diffusion-mismatch ratio, ADC decrease within the lesion, and severity of neurological deficit at admission.
Predictive Parameters
Clinical parameters have previously been used to predict the development of MMI. Coma on admission13 and early nausea and vomiting14 were found to correlate with fatal brain edema, and initial NIHSS score at admission was higher in patients who were dead or dependent 1 month after stroke.37 In our study we found a NIHSS score 19 to be highly sensitive for the prediction of MMI. However, comparable to previous reports, specificity of this clinical score was low.
Similarly, carotid-T occlusion has been reported to predict fatal brain swelling with high specificity (83%) but low sensitivity (53%).15 We found comparable results and conclude that neither clinical assessment nor vessel occlusion allows a reliable prediction of MMI. Therefore, additional parameters need to be established.
Infarct volume has been proposed as a predictor of MMI, and several studies have focused on CCT findings. Major early signs of ischemia were found to be predictive of fatal brain edema9,14–17 or early deaths.38 Likewise, final lesion volume measured by CCT predicted fatal brain swelling.13,18 A recently published MRI study reports a 100% sensitivity and 94% specificity in the prediction of MMI for a DWI lesion volume of >145 mL within 2 to 14 hours of symptom onset.21 A drawback of this study is the heterogeneous range of time from symptom onset to MRI (2 to 14 hours; mean, 6.5 hours). It seems obvious that the predictive value of CCT or MRI will be higher the later the MRI data are acquired.
We focused on the 6-hour time window because the majority of severely affected stroke patients arrive within the first 6 hours.39,40 It is at this early stage of stroke development that therapeutic decisions must be made. Because hemicraniectomy appears to be more effective the earlier it is performed,11 it is important to identify patients at risk of MMI as early as possible.
In our study an ADC<80% >82 mL assessed within the first 6 hours (median, 3 hours) of symptom onset predicted the development of MMI with 87% sensitivity and 91% specificity. The early time point of our MRI study may be the reason why the predictive diffusion lesion volume we found was smaller than the 145 mL reported previously.21 It is well known from the literature that DWI lesions grow over time within and even beyond the first 24 hours.26,41 Cases of small lesions in early initial DWI but with large final infarctions and malignant course have been reported.42 We had a similar case within our sample: in this patient initial ADC<80% was 35 mL at 125 minutes after symptom onset. With the use of the ADC<80% threshold of >82 mL, the patient was misclassified as non-MMI but developed MMI with a final infarct volume of 268 mL measured on DWI 5 days later.
The optimal time window for MRI to predict MMI has yet to be established. In cases in which initial MRI remains doubtful, an early follow-up MRI or CCT within the first 12 hours is required.
The degree of the ADC decrease within the infarct core (ADCcore <300 mm2/s) as well as within the entire lesion (rADClesion <0.62) predicted MMI with high sensitivity and specificity. These findings are in agreement with the results from a previous MRI study in which ADC decrease in different ROIs predicted MMI.21 From a pathophysiological point of view, this can be easily explained because the extent of the ADC decrease is a function of the severity and duration of ischemia.25,43
The predictive value of the perfusion lesion volume may seem surprising. Previous studies of the predictive value of the initial perfusion lesion have been controversial. The initial PWI lesion was found to correlate only moderately with final infarct volume or clinical outcome.26,44 In contrast, infarct growth was predicted well by a severe perfusion deficit defined as regional cerebral blood flow <12 mL/100 g per minute,45 TTP >+6 seconds,46 or mean transit time >+4 seconds.47 In the present study, with the use of the TTP>+4s threshold, a perfusion lesion volume >162 mL predicted MMI with 83% sensitivity and 75% specificity.
The PWI/DWI mismatch is assumed to represent "tissue at risk of infarction" and has been suggested as a possible target for reperfusion therapy.27,28,47 In our study a small mismatch ratio (TTP>+4s/ADC<80% <2.4) predicted MMI with high sensitivity and specificity. In the absence of a multivariate analysis, it remains to be determined whether the PWI/DWI mismatch independently predicts MMI. Because the area of PWI/DWI mismatch depends directly on the DWI lesion volume, the predictive value of the mismatch may well be an effect of the DWI lesion volume itself.
In summary, we found different MRI and clinical parameters to be strong predictors of MMI. Because CIs overlap and multivariate analysis was not performed, we cannot judge which parameter acts as the strongest independent predictor. Nevertheless, there seems to be a tendency for diffusion lesion volume to be the most powerful predictor of MMI at this early stage.
Subgroup Analysis: Thrombolysis Versus No Thrombolysis
Thrombolysis has been shown to result in higher recanalization rates, smaller final lesion volumes, and better outcome in patients with acute occlusion of the MCA.27,29,30,38,48 It is obvious that successful thrombolysis resulting in early nutritive reperfusion may substantially alter the risk of developing MMI in patients with carotid-T occlusion or MCA main stem occlusion. To address the question of the extent to which thrombolysis influences the prediction of MMI, we compared patients treated with thrombolysis with those not treated with thrombolysis (Table 5). Because of small sample size, ROC analysis was not performed separately for subgroups.
|
Because of the exclusion criteria for thrombolysis (early ischemic signs covering more than one third of MCA territory), lesion volumes were larger and carotid-T occlusion was more frequent in the group not treated by thrombolysis, whereas the severity of the neurological deficit appeared to be similar for both groups. Because diffusion lesion volume was found to be a powerful predictor of MMI, it is not surprising that the number of patients developing MMI was larger within the group of patients not treated by thrombolysis.
Misclassifications
Although MRI-derived parameters resulted in a good prediction of MMI, there were misclassifications that deserve closer analysis. The ADC<80% lesion volume >82 mL threshold resulted in 3 misclassifications that were erroneously classified as MMI. In all 3 patients, follow-up MRI revealed large infarctions with at least moderate edema and midline shift. Nevertheless, these patients remained clinically stable and did not deteriorate. They showed neither severe brain atrophy nor any other obvious reason that might explain the more benign development. Particularly when hemicraniectomy is discussed as an option, a false-positive classification as MMI is of major concern because it may result in unnecessary surgical treatment. Therefore, DWI alone is not sufficient for the prediction of MMI and must be supplemented by other clinical or imaging parameters.
In the study by Oppenheim and colleagues,21 bivariate models combining DWI lesion volume and ADC decrease in different ROIs resulted in a prediction of MMI with 100% sensitivity and specificity. Because of the small size of their sample (n=28), these results should be interpreted cautiously. We did not perform multivariate analysis because of the small sample size in our study.
There are limitations to our study. We used a retrospective design, and validation of the results in a prospective study is required. This was not a community-based study. We included all consecutive patients within a 2-year period, and we cannot rule out bias since our hospital is a referral center. Small sample size represents another limitation, leading to wide CIs and precluding multivariate analysis. Predictive models that combine 2 parameters may further improve prediction, and some effects may be too small to be detected within such a small sample.
|
Conclusions |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionConclusionsReferences |
|---|
We showed that acute stroke MRI allows the prediction of malignant MCA infarction within a very early time window of 6 hours of stroke onset. ADC<80% lesion volume, TTP>+4s lesion volume, TTP/ADC mismatch ratio, ADC decrease within the lesion, and NIHSS score are parameters that predict MMI with high sensitivity and specificity. MMI has a high mortality that is reduced by decompressive surgery, especially when surgery is performed early. Stroke MRI can help in the selection of patients for early hemicraniectomy or other aggressive therapeutic approaches before the onset of clinical deterioration.
|
Acknowledgments |
|---|
We acknowledge helpful discussions with our partners within the Kompetenznetzwerk Schlaganfall, sponsored by the Bundesministerium für Bildung und Forschung (B5; No. 01GI9902/4). Rene Knab is supported by a grant within this project.
|
Footnotes |
|---|
Presented in part at the 11th European Stroke Conference, Geneva, Switzerland, May 31, 2002.
Received January 21, 2003; revision received March 20, 2003; accepted April 11, 2003.
|
References |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionConclusionsReferences |
|---|
1. Ng LK, Nimmannitya J. Massive cerebral infarction with severe brain swelling: a clinicopathological study. Stroke. 1970; 1: 158–163.
2. Shaw CM, Alvord EC, Berry CR. Swelling of the brain following ischemic infarction with arterial occlusion. Arch Neurol. 1959; 1: 161–177.[Medline] [Order article via Infotrieve]
3. Ropper AH, Shafran B. Brain edema after stroke: clinical syndrome and intracranial pressure. Arch Neurol. 1984; 41: 26–29.
4. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. "Malignant" middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996; 53: 309–315.
5. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991; 337: 1521–1526.[CrossRef][Medline] [Order article via Infotrieve]
6. Kaste M, Waltimo O. Prognosis of patients with middle cerebral artery occlusion. Stroke. 1976; 7: 482–485.
7. Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory: etiology and outcome patterns. Neurology. 1998; 50: 341–350.
8. Berrouschot J, Sterker M, Bettin S, Koster J, Schneider D. Mortality of space-occupying (‘malignant’) middle cerebral artery infarction under conservative intensive care. Intensive Care Med. 1998; 24: 620–623.[CrossRef][Medline] [Order article via Infotrieve]
9. Kasner SE, Demchuk AM, Berrouschot J, Schmutzhard E, Harms L, Verro P, Chalela JA, Abbur R, McGrade H, Christou I, Krieger DW. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke. 2001; 32: 2117–2123.
10. Steiger HJ. Outcome of acute supratentorial cerebral infarction in patients under 60: development of a prognostic grading system. Acta Neurochir (Wien). 1991; 111: 73–79.
11. Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998; 29: 1888–1893.
12. Steiner T, Ringleb P, Hacke W. Treatment options for large hemispheric stroke. Neurology. 2001; 57: S61–S68.
13. Pullicino PM, Alexandrov AV, Shelton JA, Alexandrova NA, Smurawska LT, Norris JW. Mass effect and death from severe acute stroke. Neurology. 1997; 49: 1090–1095.
14. Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke. 1999; 30: 287–292.
15. Kucinski T, Koch C, Grzyska U, Freitag HJ, Kromer H, Zeumer H. The predictive value of early CT and angiography for fatal hemispheric swelling in acute stroke. AJNR Am J Neuroradiol. 1998; 19: 839–846.[Abstract]
16. Haring HP, Dilitz E, Pallua A, Hessenberger G, Kampfl A, Pfausler B, Schmutzhard E. Attenuated corticomedullary contrast: an early cerebral computed tomography sign indicating malignant middle cerebral artery infarction: a case-control study. Stroke. 1999; 30: 1076–1082.
17. von Kummer R, Meyding-Lamade U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol. 1994; 15: 9–18.[Abstract]
18. Mori K, Aoki A, Yamamoto T, Horinaka N, Maeda M. Aggressive decompressive surgery in patients with massive hemispheric embolic cerebral infarction associated with severe brain swelling. Acta Neurochir (Wien). 2001; 143: 483–492.
19. Firlik AD, Yonas H, Kaufmann AM, Wechsler LR, Jungreis CA, Fukui MB, Williams RL. Relationship between cerebral blood flow and the development of swelling and life-threatening herniation in acute ischemic stroke. J Neurosurg. 1998; 89: 243–249.[Medline] [Order article via Infotrieve]
20. Berrouschot J, Barthel H, von Kummer R, Knapp WH, Hesse S, Schneider D. 99mTechnetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke. 1998; 29: 2556–2562.
21. Oppenheim C, Samson Y, Manai R, Lala T, Vandamme X, Crozier S, Srour A, Cornu P, Dormont D, Rancurel G, Marsault C. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke. 2000; 31: 2175–2181.
22. Hacke W, Warach S. Diffusion-weighted MRI as an evolving standard of care in acute stroke. Neurology. 2000; 54: 1548–1549.
23. Warach S. Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Curr Control Trials Cardiovasc Med. 2001; 2: 38–44.[CrossRef][Medline] [Order article via Infotrieve]
24. Albers GW. Expanding the window for thrombolytic therapy in acute stroke: the potential role of acute MRI for patient selection. Stroke. 1999; 30: 2230–2237.
25. Röther J. CT and MRI in the diagnosis of acute stroke and their role in thrombolysis. Thromb Res. 2001; 103: S125–S133.
26. Schellinger PD, Fiebach JB, Jansen O, Ringleb PA, Mohr A, Steiner T, Heiland S, Schwab S, Pohlers O, Ryssel H, et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol. 2001; 49: 460–469.[CrossRef][Medline] [Order article via Infotrieve]
27. Röther J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, Fiehler J, Jansen O, Kucinski T, Schoder V, et al, and the Kompetenznetzwerk Schlaganfall Study Group. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke. 2002; 3: 2438–2445.
28. Warach S. Thrombolysis in stroke beyond three hours: targeting patients with diffusion and perfusion MRI. Ann Neurol. 2002; 51: 11–13.[CrossRef][Medline] [Order article via Infotrieve]
29. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, et al, for the Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998; 352: 1245–1251.[CrossRef][Medline] [Order article via Infotrieve]
30. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 282: 2003–2011.
31. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989; 20: 864–870.
32. Granger CV, Dewis LS, Peters NC, Sherwood CC, Barret JE. Stroke rehabilitation: analysis of repeated Barthel Index measures. Arch Phys Med Rehabil. 1979; 60: 14–17.[Medline] [Order article via Infotrieve]
33. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988; 19: 604–607.
34. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24: 35–41.
35. Fiehler J, Foth M, Kucinski T, Knab R, von Bezold M, Weiller C, Zeumer H, Röther J. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke. 2002; 33: 79–86.
36. Guangqin MA, Hall WJ. Confidence bands for receiver operating characteristic curves. Medical Decision Making. 1993; 13: 191–197.
37. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke. 2000; 31: 2597–2602.
38. Roberts HC, Dillon WP, Furlan AJ, Wechlser LR, Rowley HA, Fischbein NJ, Higashida RT, Kase C, Schulz GA, Lu Y, Firszt CM. Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial. Stroke. 2002; 33: 1557–1565.
39. Lacy CR, Suh DC, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke. 2001; 32: 63–69.
40. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke. 2000; 31: 2585–2590.
41. Lansberg MG, O’Brien MW, Tong DC, Moseley ME, Albers GW. Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Arch Neurol. 2001; 58: 613–617.
42. Neumann-Haefelin T, Sitzer M, du Mesnil de Rochemont R, Lanferman H. Prediction of malignant MCA infarction with DWI: pitfalls in hyperacute stroke. Stroke. 2001; 32: 580–583.
43. Fiehler J, Fiebach JB, Gass A, Hoehn M, Kucinski T, Neumann-Haefelin T, Schellinger PD, Siebler M, Villringer A, Röther J. Diffusion-weighted imaging in acute stroke: a tool of uncertain value? Cerebrovasc Dis. 2002; 14: 187–196.[CrossRef][Medline] [Order article via Infotrieve]
44. Rohl L, Geday J, Ostergaard L, Simonsen CZ, Vestergaard-Poulsen P, Andersen G, Le Bihan D, Gyldensted C. Correlation between diffusion- and perfusion-weighted MRI and neurological deficit measured by the Scandinavian Stroke Scale and Barthel Index in hyperacute subcortical stroke (< or = 6 hours). Cerebrovasc Dis. 2001; 12: 203–213.[CrossRef][Medline] [Order article via Infotrieve]
45. Fiehler J, von Bezold M, Kucinski T, Knab R, Eckert B, Wittkugel O, Zeumer H, Röther J. Cerebral blood flow predicts lesion growth in acute stroke patients. Stroke. 2002; 33: 2421–2425.
46. Neumann-Haefelin T, Wittsack HJ, Wenserski F, Siebler M, Seitz RJ, Modder U, Freund HJ. Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke. 1999; 30: 1591–1597.
47. Parsons MW, Barber PA, Davis SM. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology. 2002; 58: 1707.
48. Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, Pohlers O, Ryssel H, Sartor K, Hacke W. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke. 2000; 31: 1318–1328.
This article has been cited by other articles:
 |
|
 |
|
  R. E. Latchaw, M. J. Alberts, M. H. Lev, J. J. Connors, R. E. Harbaugh, R. T. Higashida, R. Hobson, C. S. Kidwell, W. J. Koroshetz, V. Mathews, et al. Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association Stroke, November 1, 2009; 40(11): 3646 - 3678. [Full Text] [PDF]
|
|
|
|
 |
|
 A Kruetzelmann, S Siemonsen, C Gerloff, M Rosenkranz, J Rother, J Fiehler, and G Thomalla Thrombolysis targeting MRI defined tissue at risk in minor stroke J. Neurol. Neurosurg. Psychiatry, October 1, 2009; 80(10): 1156 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Sims, L. R. Gharai, P. W. Schaefer, M. Vangel, E. S. Rosenthal, M. H. Lev, and L. H. Schwamm ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes Neurology, June 16, 2009; 72(24): 2104 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Alawneh, R. R. Moustafa, and J.-C. Baron Hemodynamic Factors and Perfusion Abnormalities in Early Neurological Deterioration Stroke, June 1, 2009; 40(6): e443 - e450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.M. Provenzale, K. Shah, U. Patel, and D.C. McCrory Systematic Review of CT and MR Perfusion Imaging for Assessment of Acute Cerebrovascular Disease AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1476 - 1482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Moldes, T. Sobrino, M. Millan, M. Castellanos, N. Perez de la Ossa, R. Leira, J. Serena, J. Vivancos, A. Davalos, and J. Castillo High Serum Levels of Endothelin-1 Predict Severe Cerebral Edema in Patients With Acute Ischemic Stroke Treated With t-PA Stroke, July 1, 2008; 39(7): 2006 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cohnen, H.-J. Wittsack, S. Assadi, K. Muskalla, A. Ringelstein, L.W. Poll, A. Saleh, and U. Modder Radiation exposure of patients in comprehensive computed tomography of the head in acute stroke. AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1741 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jaramillo, F. Gongora-Rivera, J. Labreuche, J. -J. Hauw, and P. Amarenco Predictors for malignant middle cerebral artery infarctions: A postmortem analysis Neurology, March 28, 2006; 66(6): 815 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bosche, G. F. Hamann, C. Dohmen, R. Graf, J. Serena, M. Castellanos, J. Castillo, M. Blanco, and A. Davalos There Is More to it Than: the Greater the Infarction Volume, the More Probable Is a Malignant MCA Infarction Stroke, March 1, 2006; 37(3): 762 - 764. [Full Text] [PDF]
|
|
|
|
|
|
M. Wintermark, M. Sesay, E. Barbier, K. Borbely, W. P. Dillon, J. D. Eastwood, T. C. Glenn, C. B. Grandin, S. Pedraza, J.-F. Soustiel, et al. Comparative Overview of Brain Perfusion Imaging Techniques Stroke, September 1, 2005; 36(9): e83 - e99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Serena, M. Blanco, M. Castellanos, Y. Silva, J. Vivancos, M. A. Moro, R. Leira, I. Lizasoain, J. Castillo, and A. Davalos The Prediction of Malignant Cerebral Infarction by Molecular Brain Barrier Disruption Markers Stroke, September 1, 2005; 36(9): 1921 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Berger, P. Schramm, and S. Schwab Reduction of Diffusion-Weighted MRI Lesion Volume After Early Moderate Hypothermia in Ischemic Stroke Stroke, June 1, 2005; 36(6): e56 - e58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sobesky, O. Z. Weber, F.-G. Lehnhardt, V. Hesselmann, A. Thiel, C. Dohmen, A. Jacobs, M. Neveling, and W.-D. Heiss Which Time-to-Peak Threshold Best Identifies Penumbral Flow?: A Comparison of Perfusion-Weighted Magnetic Resonance Imaging and Positron Emission Tomography in Acute Ischemic Stroke Stroke, December 1, 2004; 35(12): 2843 - 2847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Foerch, B. Otto, O. C. Singer, T. Neumann-Haefelin, B. Yan, J. Berkefeld, H. Steinmetz, and M. Sitzer Serum S100B Predicts a Malignant Course of Infarction in Patients With Acute Middle Cerebral Artery Occlusion Stroke, September 1, 2004; 35(9): 2160 - 2164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Warach and J.-C. Baron Neuroimaging Stroke, February 1, 2004; 35(2): 351 - 353. [Full Text] [PDF]
|
|
|
|
|
|
C. Berger and S. Schwab Editorial Comment--"Malignant" or Not: Is There a Role for In Vivo Neurochemistry? Stroke, December 1, 2003; 34(12): 2914 - 2915. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||